Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Total Current Liabilities (2019 - 2025)

Pulmonx has reported Total Current Liabilities over the past 7 years, most recently at $20.1 million for Q4 2025.

  • Quarterly Total Current Liabilities fell 17.92% to $20.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.1 million through Dec 2025, down 17.92% year-over-year, with the annual reading at $20.1 million for FY2025, 17.92% down from the prior year.
  • Total Current Liabilities was $20.1 million for Q4 2025 at Pulmonx, down from $22.9 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $24.9 million in Q1 2025 and troughed at $14.0 million in Q1 2021.
  • The 5-year median for Total Current Liabilities is $20.3 million (2022), against an average of $20.0 million.
  • Year-over-year, Total Current Liabilities soared 46.41% in 2021 and then fell 17.92% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $17.6 million in 2021, then grew by 5.37% to $18.5 million in 2022, then grew by 25.23% to $23.2 million in 2023, then grew by 5.53% to $24.4 million in 2024, then fell by 17.92% to $20.1 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Total Current Liabilities are $20.1 million (Q4 2025), $22.9 million (Q3 2025), and $22.4 million (Q2 2025).